Steward Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-132
Closed -$3K 715
2022
Q4
$3K Buy
+132
New +$4.19K ﹤0.01% 244
2022
Q3
Sell
-132
Closed -$4K 137
2022
Q2
$4K Hold
132
﹤0.01% 361
2022
Q1
$6K Hold
132
0.01% 226
2021
Q4
$8K Buy
+132
New +$9.13K 0.01% 165

Other funds holding ARKG

Steward Financial Group's ARKG Position: Q1 2023 in Review

Steward Financial Group sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 132 shares — an estimated $3K sold.

Steward Financial Group first reported a position in ARKG in Q4 2021 and held it in 4 quarters. The position peaked at $8K in Q4 2021. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

  • Steward Financial Group reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
  • Steward Financial Group sold 132 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $3K.
  • Steward Financial Group first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 4 quarters.
  • Steward Financial Group's ARK Genomic Revolution ETF position peaked at $8K in Q4 2021.
  • 295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Steward Financial Group's 13F filing for Q1 2023, filed 5 May 2023.